Summary
30 / 100 · Bulios Score
What speaks for it
- It holds more cash than debt: $47.5M against $4.90M.
- Analysts expect revenue to grow by 13% this fiscal year.
What to watch
- The company made a loss over the last 12 months.
- Revenue fell by 14% a year over the last 3 years.
- The share price is above the Bulios Fair Price.
- It passes only 2 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensivePrice against the Bulios Fair Price
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue fell by 27% a year over 5 years. Over the last 3 years it fell by 14% a year. For the next fiscal year analysts expect revenue to grow by 13%.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $300.6M.
Profitability in detailIs it financially healthy?
YesOver the last 12 months it spent more cash than it brought in. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 16
- Hold 4
- Sell 0
Today's price within the analysts' price targets
The average target of $66.8 is 123% above today's price. 80% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Grant 94%
- Service 6.3%
By region
The company reports no revenue by region.
Grant brings in 94% of revenue. Service grew fastest, by 20% a year.
Segments in detail